ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 280 filers reported holding ICU MED INC in Q4 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $304,904 | -33.6% | 2,562 | -0.5% | 0.00% | -100.0% |
| Q2 2023 | $459,017 | -22.8% | 2,576 | -28.6% | 0.00% | 0.0% |
| Q1 2023 | $594,846 | +2.8% | 3,606 | -1.8% | 0.00% | 0.0% |
| Q4 2022 | $578,424 | +1.3% | 3,673 | -3.1% | 0.00% | 0.0% |
| Q3 2022 | $571,075 | -10.8% | 3,792 | -2.7% | 0.00% | -50.0% |
| Q2 2022 | $640,000 | -2.0% | 3,898 | +32.9% | 0.00% | +100.0% |
| Q1 2022 | $653,000 | -6.2% | 2,933 | +0.0% | 0.00% | 0.0% |
| Q4 2021 | $696,000 | -8.5% | 2,932 | -10.1% | 0.00% | -50.0% |
| Q3 2021 | $761,000 | +12.9% | 3,261 | -0.5% | 0.00% | +100.0% |
| Q2 2021 | $674,000 | -16.2% | 3,276 | -16.3% | 0.00% | -50.0% |
| Q1 2021 | $804,000 | -8.3% | 3,912 | -4.3% | 0.00% | 0.0% |
| Q4 2020 | $877,000 | +12.6% | 4,087 | -4.1% | 0.00% | 0.0% |
| Q3 2020 | $779,000 | -3.9% | 4,261 | -3.2% | 0.00% | 0.0% |
| Q2 2020 | $811,000 | -10.3% | 4,403 | -1.8% | 0.00% | 0.0% |
| Q1 2020 | $904,000 | +7.2% | 4,482 | -0.5% | 0.00% | 0.0% |
| Q4 2019 | $843,000 | +32.8% | 4,504 | +13.2% | 0.00% | +100.0% |
| Q3 2019 | $635,000 | -36.8% | 3,980 | -0.3% | 0.00% | -50.0% |
| Q2 2019 | $1,005,000 | -98.1% | 3,991 | -98.2% | 0.00% | -98.3% |
| Q1 2019 | $53,132,000 | -14.4% | 222,004 | -17.8% | 0.12% | -22.2% |
| Q4 2018 | $62,047,000 | +4469.0% | 270,205 | +5525.8% | 0.15% | +5000.0% |
| Q3 2018 | $1,358,000 | -5.8% | 4,803 | -2.1% | 0.00% | 0.0% |
| Q2 2018 | $1,441,000 | -15.1% | 4,906 | -27.1% | 0.00% | -25.0% |
| Q1 2018 | $1,698,000 | +15.7% | 6,728 | -0.9% | 0.00% | +33.3% |
| Q4 2017 | $1,467,000 | +12.7% | 6,791 | -3.1% | 0.00% | 0.0% |
| Q3 2017 | $1,302,000 | +7.7% | 7,008 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,209,000 | +38.8% | 7,008 | +22.8% | 0.00% | +50.0% |
| Q1 2017 | $871,000 | +3.6% | 5,705 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $841,000 | +16.6% | 5,705 | 0.0% | 0.00% | +100.0% |
| Q3 2016 | $721,000 | +12.1% | 5,705 | 0.0% | 0.00% | -50.0% |
| Q2 2016 | $643,000 | +8.2% | 5,705 | 0.0% | 0.00% | +100.0% |
| Q1 2016 | $594,000 | -7.6% | 5,705 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $643,000 | +2.9% | 5,705 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $625,000 | -0.6% | 5,705 | -13.3% | 0.00% | +100.0% |
| Q2 2015 | $629,000 | +2.6% | 6,580 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $613,000 | +13.7% | 6,580 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $539,000 | +27.7% | 6,580 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $422,000 | +5.5% | 6,580 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $400,000 | +1.5% | 6,580 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $394,000 | -6.0% | 6,580 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $419,000 | -6.3% | 6,580 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $447,000 | -5.7% | 6,580 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $474,000 | – | 6,580 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |